Lipid profile changes after pomegranate consumption: A systematic review and meta-analysis of randomized controlled trials

Phytomedicine

Volumn 23, Issue 11, 2016, Pages 1103-1112

  Sahebkar, Amirhossein ^a,b   Simental Mendía, Luis E ^c   Giorgini, Paolo ^d   Ferri, Claudio ^d   Grassi, Davide ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Antioxidants; Cardiovascular risk; Flavonoids; Lipid profile; Pomegranate

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; FOOD INTAKE; HUMAN; LIPID BLOOD LEVEL; POMEGRANATE; POMEGRANATE JUICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; LYTHRACEAE; META ANALYSIS; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHOLESTEROL; DIETARY SUPPLEMENTS; HUMANS; LIPIDS; PUNICACEAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84982227970     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.12.014     Document Type: Review

References (55)

1. Al-Muammar, M.N., Khan, F., Obesity: the preventive role of the pomegranate (Punica granatum). Nutrition 28 (2012), 595–604.
2. Asghari, G., Sheikholeslami, S., Mirmiran, P., Chary, A., Hedayati, M., Shafiee, A., Azizi, F., Effect of pomegranate seed oil on serum TNF-α level in dyslipidemic patients. Int. J. Food Sci. Nutr. 63:3 (2012), 368–371.
3. Asgary, S., Sahebkar, A., Afshani, M.R., Keshvari, M., Haghjooyjavanmard, S., Rafieian-Kopaei, M., Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother. Res. 28:2 (2014), 193–199.
4. Aviram, M., Dornfeld, L., Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158:1 (2001), 195–198.
5. Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, N., Presser, D., Attias, J., Liker, H., Hayek, T., Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr. 23:3 (2004), 423–433.
6. Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., Fuhrman, B., Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 71:5 (2000), 1062–1076.
7. Basu, A., Penugonda, K., Pomegranate juice: a heart-healthy fruit juice. Nutr. Rev. 67:1 (2009), 49–56.
8. Borenstein, M., Hedges, L., Higgins, J., Rothstein, H., Comprehensive Meta-Analysis Version 2. 2005, Biostat, Englewood, NJ.
9. Caceres, A., Giron, L.M., Alvarado, S.R., Torres, M.F., Screening of antimicrobial activity of plants popularly used in guatemala for the treatment of dermatomucosal diseases. J. Ethnopharmacol. 20:3 (1987), 223–237.
10. Cerdá, B., Espín, JC., Parra, S., Martínez, P., Tomás-Barberán, FA., The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur. J. Nutr. 43:4 (2004), 205–220.
11. Cerdá, B., Soto, C., Albaladejo, M.D., Martínez, P., Sánchez-Gascón, F., Tomás-Barberán, F., Espín, J.C., Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial. Eur. J. Clin. Nutr. 60:2 (2006), 245–253.
12. Chen, L., Xin, X., Yuan, Q., Su, D., Liu, W., Phytochemical properties and antioxidant capacities of various colored berries. J. Sci. Food Agric. 94 (2014), 180–188.
13. Davidson, M.H., Maki, K.C., Dicklin, M.R., Feinstein, S.B., Witchger, M., Bell, M., McGuire, D.K., Provost, J.C., Liker, H., Aviram, M., Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am. J. Cardiol. 104:7 (2009), 936–942.
14. Delahoy, P.J., Magliano, D.J., Webb, K., Grobler, M., Liew, D., The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin. Ther. 31:2 (2009), 236–244.
15. Duval, S., Tweedie, R., Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:2 (2000), 455–463.
16. EFSA Panel on Dietetic Products, Nutrition and allergies (NDA). EFSA J., 8(10), 2010, 1750.
17. Esmaillzadeh, A., Tahbaz, F., Gaieni, I., Alavi-Majd, H., Azadbakht, L., Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J. Med. Food 7:3 (2004), 305–308.
18. Faria, A., Monteiro, R., Mateus, N., Azevedo, I., Calhau, C., Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress. Eur. J. Nutr. 46 (2007), 271–278.
19. Ferretti, G., Bacchetti, T., Sahebkar, A., Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog. Lipid Res. 60 (2015), 50–73.
20. Gil, M.I., Tomás-Barberán, F.A., Hess-Pierce, B., Holcroft, D.M., Kader, A.A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48 (2000), 4581–4589.
21. González-Ortiz, M., Martínez-Abundis, E., Espinel-Bermúdez, MC., Pérez-Rubio, KG., Effect of pomegranate juice on insulin secretion and sensitivity in patients with obesity. Ann. Nutr. Metab. 58:3 (2011), 220–223.
22. Grassi, D., Desideri, G., Ferri, L., Tiberti, S., Ferri, C., Cocoa and lipid profile: a fat paradox?. AgroFood Ind. Hi-Tech 20:6 (2009), 2–4.
23. Grassi, D., Desideri, G., Ferri, C., Flavonoids: antioxidants against atherosclerosis. Nutrients 2:8 (2010), 889–902.
24. Grassi, D., Desideri, G., Ferri, C., Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis. Curr. Pharm. Biotechnol. 12:9 (2011), 1343–1353.
25. Hajimahmoodi, M., Oveisi, M.R., Sadeghi, N., Jannat, B., Nateghi, M., Antioxidant capacity of plasma after pomegranate intake in human volunteers. Acta Med. Iran. 47:2 (2009), 125–132.
26. Hamoud, S., Hayek, T., Volkova, N., Attias, J., Moscoviz, D., Rosenblat, M., Aviram, M., Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study. Atherosclerosis 232:1 (2014), 204–210.
27. Heber, D., Seeram, NP., Wyatt, H., Henning, SM., Zhang, Y., Ogden, LG., Dreher, M., Hill, JO., Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. J. Agric. Food Chem. 55:24 (2007), 10050–10054.
28. Higgins J.P.T. and Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 [Updated March 2011]. The Cochrane Collaboration. 2011. http://handbook.cochrane.org.
29. Hontecillas, R., Diguardo, M., Duran, E., Orpi, M., Bassaganya-Riera, J., Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue. Clin. Nutr. 27:5 (2008), 764–772.
30. Hontecillas, R., O'Shea, M., Einerhand, A., Diguardo, M., Bassaganya-Riera, J., Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J. Am. Coll. Nutr. 28:2 (2009), 184–195.
31. Hooper, L., Kroon, P.A., Rimm, E.B., Cohn, J.S., Harvey, I., Le Cornu, K.A., Ryder, J.J., Hall, W.L., Cassidy, A., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88:1 (2008), 38–50.
32. Hsu, S.C., Huang, C.J., Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice. J. Nutr. Biochem. 18:2 (2007), 86–96.
33. Ikeda, I., Imasato, Y., Sasaki, E., Nakayama, M., Nagao, H., Takeo, T., Yayabe, F., Sugano, M., Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim. Biophys. Acta 1127:2 (1992), 141–146.
34. Jang, A., Srinivasan, P., Lee, N.Y., Song, H.P., Lee, J.W., Lee, M., Jo, C., Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice. Chem. Biol. Interact. 174:2 (2008), 109–117.
35. Jurenka, J.S., Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev. 13:2 (2008), 128–144.
36. Kulkarni, A.P., Mahal, H.S., Kapoor, S., Aradhya, S.M., In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J. Agric. Food Chem. 55 (2007), 1491–1500.
37. Kurosawa, T., Itoh, F., Nozaki, A., Nakano, Y., Katsuda, S., Osakabe, N., Tsubone, H., Kondo, K., Itakura, H., Suppressive effects of cacao liquor polyphenols (CLP) on LDL oxidation and the development of atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits. Atherosclerosis 179:2 (2005), 237–246.
38. Lansky, E.P., Newman, R.A., Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol. 109:2 (2007), 177–206.
39. Larrosa, M., García-Conesa, M.T., Espín, J.C., Tomás-Barberán, F.A., Ellagitannins, ellagic acid and vascular health. Mol. Asp. Med. 31:6 (2010), 513–539.
40. Medjakovic, S., Jungbauer, A., Pomegranate: a fruit that ameliorates metabolic syndrome. Food Funct. 4:1 (2013), 19–39.
41. Mertens-Talcott, S.U., Jilma-Stohlawetz, P., Rios, J., Hingorani, L., Derendorf, H., Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J. Agric. Food Chem. 54:23 (2006), 8956–8961.
42. Mirmiran, P., Fazeli, M.R., Asghari, G., Shafiee, A., Azizi, F., Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial. Br. J. Nutr. 104:3 (2010), 402–406.
43. Naqvi, S.A.H., Khan, M.S.Y., Vohora, S.B., Antibacterial, anti-fungal and anthelmintic investigations on Indian medicinal plants. Fitoterapia 62:3 (1991), 221–228.
44. Park, J.E., Kim, J.Y., Kim, J., Kim, Y.J., Kim, M.J., Kwon, S.W., Kwon, O., Pomegranate vinegar beverage reduces visceral fat accumulation in association with AMPK activation in overweight women: a double-blind, randomized, and placebo-controlled trial. J. Funct. Foods 8 (2014), 274–281.
45. Rosenblat, M., Hayek, T., Aviram, M., Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 187:2 (2006), 363–371.
46. Sahebkar, A., Watts, G.F., New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin. Ther. 35:8 (2013), 1082–1098.
47. Sahebkar, A., Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother. Res. 28:5 (2014), 633–642.
48. Sahebkar, A., Chew, G.T., Watts, G.F., Recent advances in pharmacotherapy for hypertriglyceridemia. Prog. Lipid Res. 56 (2014), 47–66.
49. Saxena, A., Vikram, N.K., Role of selected Indian plants in management of type 2 diabetes: a review. J. Altern. Complement. Med 10 (2004), 369–378.
50. Shema-Didi, L., Kristal, B., Sela, S., Geron, R., Ore, L., Does pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?. Nutr. J., 13, 2014, 18.
51. Stowe, CB., The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement. Ther. Clin. Pract. 17 (2011), 113–115.
52. Sudheesh, S., Vijayalakshmi, N.R., Flavonoids from Punica granatum—potential antiperoxidative agents. Fitoterapia 76 (2005), 181–186.
53. Sumner, M.D., Elliott-Eller, M., Weidner, G., Daubenmier, J.J., Chew, M.H., Marlin, R., Raisin, C.J., Ornish, D., Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am. J. Cardiol. 96:6 (2005), 810–814.
54. Tsang, C., Smail, NF., Almoosawi, S., Davidson, I., Al-Dujaili, E.A., Intake of polyphenol-rich pomegranate pure juice influences urinary glucocorticoids, blood pressure and homeostasis model assessment of insulin resistance in human volunteers. J. Nutr. Sci., 1, 2012, e9.
55. Wohlberg, J., Haoma-Soma in the world of ancient Greece. J. Psychoact. Drugs 22:3 (1990), 333–342.